This research paper presents a pooled analysis of the EMPEROR-Reduced and EMPEROR-Preserved trials, aiming to assess the impact of empagliflozin, an antidiabetic medication, across different stages of chronic kidney disease (CKD)...
Most Recent Articles
Rising Incidence and Prevalence of Heart Failure with Preserved Ejection Fraction (HFpEF): Diagnosis, Treatment, and Challenges—A JACC Scientific Statement
Heart failure with preserved ejection fraction (HFpEF) is a growing concern due to its rising incidence and prevalence, primarily driven by aging, obesity, sedentariness, and cardiometabolic disorders. Although recent...
Low Utilization of Lead Extraction in Cardiac Implantable Device-Associated Endocarditis: A Nationwide Study
Cardiac implantable electronic device (CIED)-associated infections pose significant risks and costs. Current guidelines recommend transvenous lead removal/extraction (TLE) as a primary treatment for endocarditis in CIED patients...
Potential Benefits of Early Prostacyclin Therapy in Neonatal CDH-Associated Pulmonary Hypertension
Prostacyclin (PGI2) is a therapeutic option for treating pulmonary hypertension associated with congenital diaphragmatic hernia (CDH) in neonates. Using PGI2 can reduce the need for extracorporeal life support (ECLS). This study...
Impact of Corticosteroid Use on Mortality and Clinical Outcomes in Pediatric Cardiac Surgery: A Systematic Review
This research paper presents a systematic review and meta-analysis to investigate the impact of perioperative corticosteroid use on mortality and clinical outcomes in pediatric cardiac surgery with cardiopulmonary bypass (CPB)...